QQQ   283.78 (-0.02%)
AAPL   143.08 (+0.30%)
MSFT   246.29 (-0.45%)
META   115.73 (+0.35%)
GOOGL   93.59 (-0.13%)
AMZN   89.24 (-1.23%)
TSLA   180.46 (+4.05%)
NVDA   173.09 (+0.82%)
NIO   12.96 (-3.36%)
BABA   92.97 (-1.27%)
AMD   69.55 (-1.31%)
T   19.23 (+0.58%)
MU   55.21 (+0.02%)
CGC   3.03 (-1.94%)
F   13.28 (+1.22%)
GE   82.15 (-1.77%)
DIS   93.69 (+1.23%)
AMC   6.01 (-0.99%)
PYPL   73.92 (-0.40%)
PFE   51.93 (+0.29%)
NFLX   323.75 (+4.35%)
QQQ   283.78 (-0.02%)
AAPL   143.08 (+0.30%)
MSFT   246.29 (-0.45%)
META   115.73 (+0.35%)
GOOGL   93.59 (-0.13%)
AMZN   89.24 (-1.23%)
TSLA   180.46 (+4.05%)
NVDA   173.09 (+0.82%)
NIO   12.96 (-3.36%)
BABA   92.97 (-1.27%)
AMD   69.55 (-1.31%)
T   19.23 (+0.58%)
MU   55.21 (+0.02%)
CGC   3.03 (-1.94%)
F   13.28 (+1.22%)
GE   82.15 (-1.77%)
DIS   93.69 (+1.23%)
AMC   6.01 (-0.99%)
PYPL   73.92 (-0.40%)
PFE   51.93 (+0.29%)
NFLX   323.75 (+4.35%)
QQQ   283.78 (-0.02%)
AAPL   143.08 (+0.30%)
MSFT   246.29 (-0.45%)
META   115.73 (+0.35%)
GOOGL   93.59 (-0.13%)
AMZN   89.24 (-1.23%)
TSLA   180.46 (+4.05%)
NVDA   173.09 (+0.82%)
NIO   12.96 (-3.36%)
BABA   92.97 (-1.27%)
AMD   69.55 (-1.31%)
T   19.23 (+0.58%)
MU   55.21 (+0.02%)
CGC   3.03 (-1.94%)
F   13.28 (+1.22%)
GE   82.15 (-1.77%)
DIS   93.69 (+1.23%)
AMC   6.01 (-0.99%)
PYPL   73.92 (-0.40%)
PFE   51.93 (+0.29%)
NFLX   323.75 (+4.35%)
QQQ   283.78 (-0.02%)
AAPL   143.08 (+0.30%)
MSFT   246.29 (-0.45%)
META   115.73 (+0.35%)
GOOGL   93.59 (-0.13%)
AMZN   89.24 (-1.23%)
TSLA   180.46 (+4.05%)
NVDA   173.09 (+0.82%)
NIO   12.96 (-3.36%)
BABA   92.97 (-1.27%)
AMD   69.55 (-1.31%)
T   19.23 (+0.58%)
MU   55.21 (+0.02%)
CGC   3.03 (-1.94%)
F   13.28 (+1.22%)
GE   82.15 (-1.77%)
DIS   93.69 (+1.23%)
AMC   6.01 (-0.99%)
PYPL   73.92 (-0.40%)
PFE   51.93 (+0.29%)
NFLX   323.75 (+4.35%)
NASDAQ:SIBN

SI-BONE - SIBN Stock Forecast, Price & News

$12.88
-0.03 (-0.23%)
(As of 12/9/2022 10:56 AM ET)
Add
Compare
Today's Range
$12.76
$12.97
50-Day Range
$11.23
$19.44
52-Week Range
$11.14
$23.71
Volume
793 shs
Average Volume
248,462 shs
Market Capitalization
$444.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.88

SI-BONE MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
100.9% Upside
$25.88 Price Target
Short Interest
Healthy
5.23% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.44
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$278,984 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.87) to ($1.58) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

285th out of 1,022 stocks

Surgical & Medical Instruments Industry

32nd out of 101 stocks

SIBN stock logo

About SI-BONE (NASDAQ:SIBN) Stock

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

SIBN Stock News Headlines

4 Analysts Have This to Say About SI-BONE
What 5 Analyst Ratings Have To Say About SI-BONE
JMP Securities Keeps Their Buy Rating on SI-Bone (SIBN)
Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue Estimates
Aurora Spine Is Now A Game Changer
Earnings Preview: SI-BONE
SIBN SI-BONE, Inc.
Analyst Ratings for SI-BONE
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Si-Bone Inc (SIBN)
Aurora Spine Has Three Shots On Goal
See More Headlines
Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

SIBN Company Calendar

Last Earnings
11/08/2021
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/27/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SIBN
Fax
N/A
Employees
352
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$25.88
High Stock Price Forecast
$36.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+100.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-56,570,000.00
Pretax Margin
-64.76%

Debt

Sales & Book Value

Annual Sales
$90.15 million
Book Value
$4.01 per share

Miscellaneous

Free Float
32,633,000
Market Cap
$444.36 million
Optionable
Not Optionable
Beta
1.00

Key Executives

  • Ms. Laura A. Francis MBAMs. Laura A. Francis MBA (Age 55)
    CEO & Director
    Comp: $879.74k
  • Mr. Anshul Maheshwari (Age 44)
    Chief Financial Officer
    Comp: $511.05k
  • Mr. Anthony J. RecuperoMr. Anthony J. Recupero (Age 63)
    Pres of Commercial Operations
    Comp: $665.91k
  • Mr. Michael A. PisetskyMr. Michael A. Pisetsky (Age 44)
    Sr. VP of Operations & Admin., Sec. and Chief Legal Officer
  • Mr. Jeff Bertolini
    Sr. VP of Operations & Information Technology
  • Dr. Scott A. Yerby (Age 54)
    Sr. VP of Engineering & CTO
  • Mr. Joseph W. Powers (Age 62)
    VP of Corp. Marketing
  • Ms. Aimee Einstein
    VP of People & Culture
  • Dr. Daniel Joseph Cher (Age 57)
    Sr. VP of Clinical & Regulatory Affairs
  • Dr. W. Carlton Reckling (Age 60)
    Chief Medical Officer & VP of Medical Affairs













SIBN Stock - Frequently Asked Questions

Should I buy or sell SI-BONE stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SI-BONE in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SIBN shares.
View SIBN analyst ratings
or view top-rated stocks.

What is SI-BONE's stock price forecast for 2023?

7 analysts have issued 12-month price objectives for SI-BONE's shares. Their SIBN share price forecasts range from $17.00 to $36.00. On average, they expect the company's stock price to reach $25.88 in the next year. This suggests a possible upside of 100.9% from the stock's current price.
View analysts price targets for SIBN
or view top-rated stocks among Wall Street analysts.

How have SIBN shares performed in 2022?

SI-BONE's stock was trading at $22.21 at the start of the year. Since then, SIBN shares have decreased by 42.0% and is now trading at $12.88.
View the best growth stocks for 2022 here
.

When is SI-BONE's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our SIBN earnings forecast
.

How were SI-BONE's earnings last quarter?

SI-BONE, Inc. (NASDAQ:SIBN) released its quarterly earnings results on Monday, November, 8th. The company reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.42) by $0.06. The company earned $22.29 million during the quarter, compared to analysts' expectations of $22.71 million. SI-BONE had a negative net margin of 64.76% and a negative trailing twelve-month return on equity of 54.88%. During the same quarter in the previous year, the business posted ($0.33) EPS.

What guidance has SI-BONE issued on next quarter's earnings?

SI-BONE updated its FY 2022 earnings guidance on Monday, November, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $104.00 million-$105.00 million, compared to the consensus revenue estimate of $107.13 million.

What is Jeffrey Dunn's approval rating as SI-BONE's CEO?

10 employees have rated SI-BONE Chief Executive Officer Jeffrey Dunn on Glassdoor.com. Jeffrey Dunn has an approval rating of 41% among the company's employees. This puts Jeffrey Dunn in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of SI-BONE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-BONE investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), Raytheon Technologies (RTX), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO) and CSX (CSX).

When did SI-BONE IPO?

(SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is SI-BONE's stock symbol?

SI-BONE trades on the NASDAQ under the ticker symbol "SIBN."

Who are SI-BONE's major shareholders?

SI-BONE's stock is owned by many different retail and institutional investors. Top institutional shareholders include Brown Advisory Inc. (10.82%), BlackRock Inc. (7.95%), First Light Asset Management LLC (5.88%), Vanguard Group Inc. (4.66%), Point72 Asset Management L.P. (3.78%) and Impax Asset Management Group plc (2.94%). Insiders that own company stock include Anshul Maheshwari, Anthony J Recupero, Anthony J Recupero, Gregory K Hinckley, Jeffrey W Dunn, Jeffrey W Dunn, Jeryl L Hilleman, Jeryl L Hilleman, John Gordon Freund, Laura Francis, Michael A Pisetsky, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling.
View institutional ownership trends
.

How do I buy shares of SI-BONE?

Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SI-BONE's stock price today?

One share of SIBN stock can currently be purchased for approximately $12.88.

How much money does SI-BONE make?

SI-BONE (NASDAQ:SIBN) has a market capitalization of $444.36 million and generates $90.15 million in revenue each year. The company earns $-56,570,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis.

How many employees does SI-BONE have?

The company employs 352 workers across the globe.

How can I contact SI-BONE?

SI-BONE's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The official website for the company is www.si-bone.com. The company can be reached via phone at (408) 207-0700 or via email at investors@si-bone.com.

This page (NASDAQ:SIBN) was last updated on 12/9/2022 by MarketBeat.com Staff